Showing results (301-310 of 941) with videos related to

Sort By:
Pageof 95
Diabetes & Vascular Disease Research|October 2, 2007
A double-blind, randomised trial of tesaglitazar versus pioglitazone in patients with type 2 diabetes mellitusHarold Bays, Jennifer McElhattan, Brian S Bryzinski, et al.
Diabetes & Vascular Disease Research|October 2, 2007
Tesaglitazar, as add-on therapy to sulphonylurea, dose-dependently improves glucose and lipid abnormalities in patients with type 2 diabetesJohn P H Wilding, Ingrid Gause-Nilsson, Anders Persson, et al.
Diabetes & Vascular Disease Research|October 2, 2007
The effects of tesaglitazar as add-on treatment to metformin in patients with poorly controlled type 2 diabetesBurkhard Göke, Ingrid Gause-Nilsson, Anders Persson, et al.
Diabetes & Vascular Disease Research|October 2, 2007
Vascular inflammatory markers in early-onset obese and type 2 diabetes subjects before and after three months' aerobic exercise trainingMensud Hatunic, Francis Finucane, Nicole Burns, et al.
Diabetes & Vascular Disease Research|October 2, 2007
Association of the T54 allele of the FABP2 gene with cardiovascular risk factors in obese Mexican subjectsErika Martínez-López, Bertha Ruíz-Madrigal, Iván Hernández-Cañaveral, et al.
Diabetes & Vascular Disease Research|May 1, 2007
Metabolic syndrome, or What you will: definitions and epidemiologyCaroline Day
Diabetes & Vascular Disease Research|July 27, 2007
The endothelium and vascular inflammation in diabetesMartin M Hartge, Thomas Unger, Ulrich Kintscher
Diabetes & Vascular Disease Research|July 27, 2007
The significance of low HDL-cholesterol levels in an ageing society at increased risk for cardiovascular diseaseEberhard Windler, Mark Schöffauer, Birgit-Christiane Zyriax
Pageof 95